Use of Proteoglycan-Genes to Engineer Vascular Tissue
使用蛋白多糖基因改造血管组织
基本信息
- 批准号:6661317
- 负责人:
- 金额:$ 21.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-30 至 2004-02-29
- 项目状态:已结题
- 来源:
- 关键词:biodegradable product bioengineering /biomedical engineering biomaterial development /preparation blood vessel prosthesis clinical research collagen elastic tissue fibrogenesis human tissue laboratory rat polymers protein isoforms proteoglycan tensile strength tissue /cell culture tissue engineering tissue support frame vascular smooth muscle
项目摘要
DESCRIPTION (provided by applicant):
One of the major limitations in vascular tissue engineering is the failure of the engineered tissue to form functional and intact elastic fibers. Recent work in our laboratory has found that by genetically engineering arterial smooth muscle cells to overexpress a specific isoform of the extracellular matrix proteoglycan, versican, elastic fibers form in vitro and in vivo when the transduced cells are seeded into injured arteries. We hypothesize that this technology can be used to create blood vessel substitutes and vascular grafts with intact and functional elastic fibers. To address this hypothesis, this proposal has the following specific aims: 1. Optimize the gene delivery system so that optimal levels of expression can be achieved in a controlled fashion to maximize elastic fiber formation. 2. Create "sheets" of engineered cells in vitro with intact elastic fibers to be used to form small diametric tubes which exhibit maximal elastogenic properties. 3. Assess the feasibility of seeding engineered cells onto micro-fiber based biodegradable polymer scaffolds wrapped around a frame to create layers of smooth muscle cells interspersed with functional elastic fibers and; 4. Determine if integrating these elastic fiber generating cells into collagen based tubular scaffolds will result in the formation of tubes with appropriate tensile strength and elastogenic properties. The overall goal of this application is to create a vascular medial layer that possesses an appropriate mixture of extracellular matrix components that mimic the natural vessel and contain intact and functional elastic fibers.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas N Wight其他文献
Fluticasone alone and in combination with salmeterol causes a reduction in the synthesis of proteoglycans by cultured bronchial smooth muscle cells
- DOI:
10.1016/s0091-6749(02)81878-4 - 发表时间:
2002-01-01 - 期刊:
- 影响因子:
- 作者:
Leonard C Altman;Susan Potter-Perigo;Gaylene Altman;Thomas N Wight - 通讯作者:
Thomas N Wight
mooth Muscle Cells of Human Veins Show An Increased Response to Injury at Valve Sites
人体静脉的平滑肌细胞对瓣膜部位损伤的反应增强
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:4.3
- 作者:
Shinsuke Kikuchi;Lihua Chen;Kevin Xiong;Yukihiro Saito;Nobuyoshi Azuma;Gale Tang;Michael Sobel;Thomas N Wight;Richard D Kenagy - 通讯作者:
Richard D Kenagy
Thomas N Wight的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas N Wight', 18)}}的其他基金
Targeting the Extracellular Matrix to Inhibit Saphenous Vein Graft (SVG) Failure
靶向细胞外基质抑制隐静脉移植物 (SVG) 失败
- 批准号:
8318591 - 财政年份:2011
- 资助金额:
$ 21.01万 - 项目类别:
Targeting the Extracellular Matrix to Inhibit Saphenous Vein Graft (SVG) Failure
靶向细胞外基质抑制隐静脉移植物 (SVG) 失败
- 批准号:
8200545 - 财政年份:2011
- 资助金额:
$ 21.01万 - 项目类别:
Extracellular Matrix in the Innate Response in Lung Inflammation
肺部炎症先天反应中的细胞外基质
- 批准号:
8005411 - 财政年份:2010
- 资助金额:
$ 21.01万 - 项目类别:
2008 Proteoglycans Gordon Research Conference
2008年蛋白多糖戈登研究会议
- 批准号:
7533667 - 财政年份:2008
- 资助金额:
$ 21.01万 - 项目类别:
Pro-Inflammatory ECM: Key Roles for Hyaluronan and Versican
促炎 ECM:透明质酸和 Versican 的关键作用
- 批准号:
7140040 - 财政年份:2005
- 资助金额:
$ 21.01万 - 项目类别:
Regulation of Cell Function by Matricellular Hevin
基质细胞 Hevin 对细胞功能的调节
- 批准号:
7407527 - 财政年份:2004
- 资助金额:
$ 21.01万 - 项目类别:
Regulation of Cell Function by Matricellular Hevin
基质细胞 Hevin 对细胞功能的调节
- 批准号:
7228904 - 财政年份:2004
- 资助金额:
$ 21.01万 - 项目类别:
Use of Proteoglycan-Genes to Engineer Vascular Tissue
使用蛋白多糖基因改造血管组织
- 批准号:
6571306 - 财政年份:2002
- 资助金额:
$ 21.01万 - 项目类别:
Use of Proteoglycan-Genes to Engineer Vascular Tissue
使用蛋白多糖基因改造血管组织
- 批准号:
6787184 - 财政年份:2002
- 资助金额:
$ 21.01万 - 项目类别:
Use of Proteoglycan-Genes to Engineer Vascular Tissue
使用蛋白多糖基因改造血管组织
- 批准号:
6844178 - 财政年份:2002
- 资助金额:
$ 21.01万 - 项目类别:














{{item.name}}会员




